Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Ampicilina

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BioVersys Starts Pivotal RIV-TARGET Trial of BV100 for HABP/VABP
    BioVersys Starts Pivotal RIV-TARGET Trial of BV100 for HABP/VABP

    16 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/16/3275014/0/en/BioVersys-Announces-First-Patient-First-Visit-in-HABP-VABP-Pivotal-Phase-3-RIV-TARGET-Trial-of-BV100.html

    GLOBENEWSWIRE
    16 Apr 2026
    Share Share
    Avenacy Launches Five Injectable Antibiotics in U.S. Market
    Avenacy Launches Five Injectable Antibiotics in U.S. Market

    17 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250317445057/en/Avenacy-Announces-Launch-of-Five-Injectable-Antibiotic-Products-in-the-U.S.-Market

    BUSINESSWIRE
    17 Mar 2025
    Share Share
    Enforcement Report - Week of May 24, 2023
    Enforcement Report - Week of May 24, 2023

    24 May 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-24-2023-89772.pdf

    FDA
    24 May 2023
    Share Share
    Enforcement Report - Week of February 22, 2023
    Enforcement Report - Week of February 22, 2023

    22 Feb 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-22-2023-51785.pdf

    FDA
    22 Feb 2023
    Share Share
    Enforcement Report - Week of October 5, 2022
    Enforcement Report - Week of October 5, 2022

    05 Oct 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-5-2022-44974.pdf

    FDA
    05 Oct 2022
    Share Share
    Piramal Critical Care Launches First to Market Generic Zinc Sulfate Injection in the U.S.
    Piramal Critical Care Launches First to Market Generic Zinc Sulfate Injection in the U.S.

    18 Aug 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/piramal-critical-care-launches-first-to-market-generic-zinc-sulfate-injection-in-the-us-301608664.html

    PRNEWSWIRE
    18 Aug 2022
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.